Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Central Nervous System Neoplasms × antineoplaston AS 2-1 × Clear all

Sponsor

Conditions

Astrocytoma 8 Glioblastoma 5 Neuroectodermal Tumors, Primitive 3 Neurocytoma 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Brain Neoplasms 2 Rhabdoid Tumor 1 Recurrence 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms, Unknown Primary 1 Mesothelioma, Malignant 1 Meningioma 1 Gliosarcoma 1 Ganglioglioma 1 Esophageal Neoplasms 1 Ependymoma 1 Craniopharyngioma 1 Adrenocortical Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Temozolomide 28 Radiotherapy 20 Bevacizumab 9 Carboplatin 8 Radiation 6 Filgrastim 6 Etoposide 6 Magnetic Resonance Spectroscopy 5 Irinotecan 5 Cyclophosphamide 5 etoposide phosphate 4 Vincristine 4 Ifosfamide 4 Granulocyte Colony-Stimulating Factor 4 Everolimus 4 X-Rays 3 Thalidomide 3 Specimen Handling 3 Phantoms, Imaging 3 Lomustine 3 Cisplatin 3 Chemotherapy, Adjuvant 3 Celecoxib 3 vitespin 2 poly ICLC 2 larotrectinib 2 Thiotepa 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡